Literature DB >> 13679594

How does the Huntington's disease mutation damage cells?

David C Rubinsztein1.   

Abstract

Huntington's Disease (HD) is an autosomal dominant neurodegenerative condition with devastating consequences. HD is caused by the expansion of a CAG trinucleotide repeat stretch in the coding sequence of the HD gene that gives rise to a long polyglutamine tract in the huntingtin protein. How this mutated protein gives rise to the disease state is controversial. In this Perspective, I discuss the results of a new study on the effects of the mutated huntingtin protein in light of previous findings and suggest that the HD mutation damages cells by perturbing multiple parallel pathways by gain-of-function and possibly also dominant negative mechanisms.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13679594     DOI: 10.1126/sageke.2003.37.pe26

Source DB:  PubMed          Journal:  Sci Aging Knowledge Environ        ISSN: 1539-6150


  8 in total

1.  Translation of HTT mRNA with expanded CAG repeats is regulated by the MID1-PP2A protein complex.

Authors:  Sybille Krauss; Nadine Griesche; Ewa Jastrzebska; Changwei Chen; Désiree Rutschow; Clemens Achmüller; Stephanie Dorn; Sylvia M Boesch; Maciej Lalowski; Erich Wanker; Rainer Schneider; Susann Schweiger
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

2.  Postnatal and adult consequences of loss of huntingtin during development: Implications for Huntington's disease.

Authors:  Eduardo E Arteaga-Bracho; Maria Gulinello; Michael L Winchester; Nandini Pichamoorthy; Jenna R Petronglo; Alicia D Zambrano; Julio Inocencio; Chirstopher D De Jesus; Joseph O Louie; Solen Gokhan; Mark F Mehler; Aldrin E Molero
Journal:  Neurobiol Dis       Date:  2016-09-10       Impact factor: 5.996

Review 3.  Studying polyglutamine diseases in Drosophila.

Authors:  Zhen Xu; Antonio Joel Tito; Yan-Ning Rui; Sheng Zhang
Journal:  Exp Neurol       Date:  2015-08-06       Impact factor: 5.330

4.  Formation and toxicity of soluble polyglutamine oligomers in living cells.

Authors:  Patrick Lajoie; Erik Lee Snapp
Journal:  PLoS One       Date:  2010-12-28       Impact factor: 3.240

5.  Huntingtin promotes cell survival by preventing Pak2 cleavage.

Authors:  Shouqing Luo; David C Rubinsztein
Journal:  J Cell Sci       Date:  2009-02-24       Impact factor: 5.285

Review 6.  The ubiquitin proteasome system in Huntington's disease and the spinocerebellar ataxias.

Authors:  Janet E Davies; Sovan Sarkar; David C Rubinsztein
Journal:  BMC Biochem       Date:  2007-11-22       Impact factor: 4.059

Review 7.  Potential therapeutic effects of the MTOR inhibitors for preventing ageing and progeria-related disorders.

Authors:  Camilla Evangelisti; Vittoria Cenni; Giovanna Lattanzi
Journal:  Br J Clin Pharmacol       Date:  2016-05-18       Impact factor: 4.335

8.  Abnormal Brain Development in Huntington' Disease Is Recapitulated in the zQ175 Knock-In Mouse Model.

Authors:  Chuangchuang Zhang; Qian Wu; Hongshuai Liu; Liam Cheng; Zhipeng Hou; Susumu Mori; Jun Hua; Christopher A Ross; Jiangyang Zhang; Peggy C Nopoulos; Wenzhen Duan
Journal:  Cereb Cortex Commun       Date:  2020-08-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.